DAX24.220 -0,3%Est505.817 -1,1%MSCI World4.343 -0,1%Top 10 Crypto10,09 +2,9%Nas25.114 +0,9%Bitcoin67.437 +0,7%Euro1,1709 -0,3%Öl110,0 +0,7%Gold4.565 -1,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NEL ASA A0B733 Siemens Energy ENER6Y NVIDIA 918422 SAP 716460 Infineon 623100 BASF BASF11 Allianz 840400 Deutsche Telekom 555750 Volkswagen (VW) vz. 766403 Lufthansa 823212 Mercedes-Benz Group (ex Daimler) 710000 Amazon 906866 Novo Nordisk A3EU6F Microsoft 870747
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX volatil -- Wall Street leichter erwartet -- Autozölle belasten VW & Co. -- GameStop will eBay übernehmen -- Berkshire Hathaway, Bitcoin, Rüstungsaktien, NEL, Lufthansa, Xanadu im Fokus
Top News
UniCredit-Aktie schwächer: Aktionäre stimmen Kapitalerhöhung für Commerzbank-Übernahme zu UniCredit-Aktie schwächer: Aktionäre stimmen Kapitalerhöhung für Commerzbank-Übernahme zu
Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

TransMedics Group Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
84,84 EUR +0,28 EUR +0,33 %
FSE
99,32 USD -0,70 USD -0,70 %
vorbörslich
BTT
finanzen.net zero
TransMedics Group jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.2,95 Mrd. EUR

KGV24,96Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PH5P

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS89377M1099

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTMDX

TransMedics Group Aktien News

DatumMeistgelesen
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TransMedics Group, Inc. - TMDX
PR NewswireTMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TransMedics Group, Inc. - TMDX
PR NewswireTransMedics Responds to Inaccurate and Misleading Claims in Recent Short-Seller Report
PR NewswireTransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
PR NewswireTransMedics to Host Investor & Analyst Day on December 10, 2024
PR NewswireTransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Third Quarter 2024 Financial Results
PR NewswireTransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireThe Ensign Group Set to Join S&P MidCap 400; Curbline Properties & TransMedics Group to Join S&P SmallCap 600
PR NewswireTransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Second Quarter 2024 Financial Results
PR NewswireTransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports First Quarter 2024 Financial Results
PR NewswireTransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Present at Upcoming March Investor Conferences
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference
PR NewswireTransMedics Reports Third Quarter 2023 Financial Results
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Report Third Quarter 2023 Financial Results on November 6, 2023
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

TransMedics Group News

TransMedics Group News: auf dieser Seite finden Sie alle TransMedics Group News und Nachrichten zur TransMedics Group Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch TransMedics Group News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um TransMedics Group News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.